Want to join the conversation?
$ENDP 2Q15 Call: XIAFLEX had a solid second quarter and remains on track with internal expectation. On a pro forma basis, US sales of XIAFLEX grew 52% compared to 2Q14 in Peyronies disease and Dupuytrens contracture. Approx. 13,000 vials of XIAFLEX were shipped during 2Q15, which is an increase of 6% compared to the same period prior year.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.